This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The replication addressed here is of a statistical nature—to be believable, reports of disease gene localizations by means of case-control association studies need to be confirmed (replicated) by independent studies. While this principle has generally worked rather well for genetic linkage analysis applied to Mendelian traits, a troubling number of “significant” associations have been reported that could not be confirmed in later studies. This issue of Neurology contains two articles, one confirming1 and one not confirming2 a previously published article showing a strong association between a single nucleotide polymorphism (SNP) genotype and multidrug resistance in epilepsy. Here is the situation.
Last year, Siddiqui et al.3 reported a strong and significant association between the CC genotype at the C3435T polymorphism in the ABCB1 gene and multidrug resistance vs multidrug responsiveness in patients with epilepsy. Sample sizes were 200 resistant and 115 responsive patients, with an associated OR (approximate relative risk) of 2.04. However, with sample sizes close to twice those in the published report and an essentially identical ascertainment scheme, Tan et al.2 in this issue of Neurology are unable to confirm the reported association. On the other hand, Zimprich et al.,1 also in this issue of the journal, with a sample size less than two thirds of that in the original report, confirm the association, although their analysis was somewhat different from those in the other two articles: they worked with a haplotype at three closely spaced SNPs (one of them being the C3435T polymorphism) and defined three instead of just two categories of multidrug resistance. How do we interpret such seemingly contradictory findings?
Various authors have addressed the reported replication of—or failure to replicate—statistical gene maps.4–8⇓⇓⇓⇓ Standards for association studies have been developed by many journals including Neurology. …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
- Association of genetic loci: Replication or not, that is the question
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.